WRBY vs. PEN, GKOS, STVN, BLCO, INSP, NARI, PRCT, NVST, IRTC, and NVCR
Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), Envista (NVST), iRhythm Technologies (IRTC), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry.
Warby Parker vs.
Warby Parker (NYSE:WRBY) and Penumbra (NYSE:PEN) are both mid-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.
Warby Parker has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500.
Penumbra has a net margin of 2.97% compared to Warby Parker's net margin of -4.39%. Penumbra's return on equity of 8.99% beat Warby Parker's return on equity.
In the previous week, Warby Parker had 8 more articles in the media than Penumbra. MarketBeat recorded 11 mentions for Warby Parker and 3 mentions for Penumbra. Penumbra's average media sentiment score of 0.50 beat Warby Parker's score of 0.42 indicating that Penumbra is being referred to more favorably in the news media.
Penumbra received 780 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 80.29% of users gave Penumbra an outperform vote while only 42.39% of users gave Warby Parker an outperform vote.
Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.
Warby Parker currently has a consensus target price of $20.92, suggesting a potential downside of 14.85%. Penumbra has a consensus target price of $258.00, suggesting a potential downside of 2.30%. Given Penumbra's stronger consensus rating and higher probable upside, analysts clearly believe Penumbra is more favorable than Warby Parker.
93.2% of Warby Parker shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 26.5% of Warby Parker shares are held by company insiders. Comparatively, 5.0% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Penumbra beats Warby Parker on 15 of the 19 factors compared between the two stocks.
Get Warby Parker News Delivered to You Automatically
Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Warby Parker Competitors List
Related Companies and Tools
This page (NYSE:WRBY) was last updated on 1/18/2025 by MarketBeat.com Staff
